77112
document
[ Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis ] . The effect of high-dose metoclopramide ( 2 mg/kg , 4 times every 2 hours ) on the emesis of patients treated with CDDP ( 80 mg/m2 ) was examined by randomized control trial . The above metoclopramide regimen significantly suppressed the frequency of vomiting on the day of CDDP administration . The duration of nausea and anorexia after CDDP treatment was also shortened by high-dose metoclopramide administration .
77113
Intervention_Pharmacological
metoclopramide
77114
Intervention_Pharmacological
high-dose metoclopramide ( 2 mg/kg
77115
Intervention_Pharmacological
metoclopramide
77116
Intervention_Pharmacological
metoclopramide
77117
Outcome_Physical
CDDP-induced emesis ]
77118
Outcome_Physical
emesis
77119
Outcome_Physical
suppressed the frequency of vomiting
77120
Outcome_Physical
nausea and anorexia